Citations (514)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (46)
Tao Ma, Jin-Ling Jiang, Wei-Xiang Qi, Jia-Yi Chen & Hao-Ping Xu. (2022) A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy. Drug Design, Development and Therapy 16, pages 2395-2406.
Read now
Read now
Roshan Katekar, Pragati Singh, Richa Garg, Saurabh Verma & Jiaur R. Gayen. (2022) Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers. Pharmaceutical Development and Technology 27:1, pages 95-107.
Read now
Read now
Raluca Borlan, Monica Focsan, Dana Maniu & Simion Astilean. (2021) Interventional NIR Fluorescence Imaging of Cancer: Review on Next Generation of Dye-Loaded Protein-Based Nanoparticles for Real-Time Feedback During Cancer Surgery. International Journal of Nanomedicine 16, pages 2147-2171.
Read now
Read now
Xing Xiao, Wei Chen, Zhe-Wei Wei, Wei-Wei Chu, Xiao-Fang Lu, Bo Li, Hong Chen, Si-Jun Meng, Teng-Fei Hao, Ji-Tao Wei, Yu-Long He & Chang-Hua Zhang. (2020) The Anti-Tumor Effect of Nab-Paclitaxel Proven by Patient-Derived Organoids. OncoTargets and Therapy 13, pages 6017-6025.
Read now
Read now
Qifang Long, Weipei Zhu, Liangsheng Guo & Li Pu. (2020) RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy. Drug Design, Development and Therapy 14, pages 5747-5756.
Read now
Read now
Rossella De Luca, Giuseppe Profita & Giuseppe Cicero. (2019) Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life. OncoTargets and Therapy 12, pages 1621-1627.
Read now
Read now
Huan-huan Wang, Zhi-guang Fu, Wei Li, Yun-xia Li, Li-sheng Zhao, Li Wen, Jian-jun Zhang & Ning Wen. (2019) The synthesis and application of nano doxorubicin- indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy for head and neck squamous cell carcinoma. International Journal of Nanomedicine 14, pages 623-638.
Read now
Read now
Stephan Lugert, Harald Unterweger, Marina Mühlberger, Christina Janko, Sebastian Draack, Frank Ludwig, Dietmar Eberbeck, Christoph Alexiou & Ralf P Friedrich. (2019) Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models. International Journal of Nanomedicine 14, pages 161-180.
Read now
Read now
Junling Li, Wei Li, Xiaojian Dai, Dafang Zhong, Yaping Ding & Xiaoyan Chen. (2019) Bioequivalence of paclitaxel protein-bound particles in patients with breast cancer: determining total and unbound paclitaxel in plasma by rapid equilibrium dialysis and liquid chromatography–tandem mass spectrometry. Drug Design, Development and Therapy 13, pages 1739-1749.
Read now
Read now
Sadia Sikder, Vrinda Gote, Meshal Alshamrani, Jeff Sicotte & Dhananjay Pal. (2019) Long-term delivery of protein and peptide therapeutics for cancer therapies. Expert Opinion on Drug Delivery 16:10, pages 1113-1131.
Read now
Read now
Fabiana de Sousa Cunha, Laise Nayra dos Santos Pereira, Thâmara Pryscilla de Costa e Silva, Roberto Alves de Sousa Luz & Anderson Nogueira Mendes. (2019) Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics. Journal of Drug Targeting 27:7, pages 732-741.
Read now
Read now
Diego Adrianzen Herrera, Nadia Ashai, Roman Perez-Soler & Haiying Cheng. (2019) Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence. Expert Opinion on Pharmacotherapy 20:1, pages 95-102.
Read now
Read now
Diwakar Jain & Wilbert Aronow. (2019) Cardiotoxicity of cancer chemotherapy in clinical practice. Hospital Practice 47:1, pages 6-15.
Read now
Read now
Ying Wang, Ke Zheng, Guangshan Xuan, Mingdong Huang & Jinping Xue. (2018) Novel pH-sensitive zinc phthalocyanine assembled with albumin for tumor targeting and treatment. International Journal of Nanomedicine 13, pages 7681-7695.
Read now
Read now
Regina-Veronicka Kalaydina, Komal Bajwa, Bessi Qorri, Alexandria Decarlo & Myron R Szewczuk. (2018) Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International Journal of Nanomedicine 13, pages 4727-4745.
Read now
Read now
Carlo Lazzaro, Carlo Barone, Francesco Caprioni, Stefano Cascinu, Alfredo Falcone, Evaristo Maiello, Michele Milella, Carmine Pinto, Michele Reni & Giampaolo Tortora. (2018) An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study. Expert Review of Pharmacoeconomics & Outcomes Research 18:4, pages 435-446.
Read now
Read now
Song Yi Lee & Hyun-Jong Cho. (2018) An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy. Drug Delivery 25:1, pages 738-749.
Read now
Read now
Ayesha Khalid, Stefano Persano, Haifa Shen, Yuliang Zhao, Elvin Blanco, Mauro Ferrari & Joy Wolfram. (2017) Strategies for improving drug delivery: nanocarriers and microenvironmental priming. Expert Opinion on Drug Delivery 14:7, pages 865-877.
Read now
Read now
Mahdi Karimi, Sajad Bahrami, Soodeh Baghaee Ravari, Parham Sahandi Zangabad, Hamed Mirshekari, Mahnaz Bozorgomid, Somayeh Shahreza, Masume Sori & Michael R. Hamblin. (2016) Albumin nanostructures as advanced drug delivery systems. Expert Opinion on Drug Delivery 13:11, pages 1609-1623.
Read now
Read now
Juan Li, Fengshan Wang, Deqing Sun & Rongmei Wang. (2016) A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours. Journal of Drug Targeting 24:7, pages 590-602.
Read now
Read now
Fanbo Jing, Wen Xu, Donghua Liu, Chenjing Wang & Zhongguo Sui. (2016) Enhanced antithrombotic effect of hirudin by bovine serum albumin nanoparticles. Journal of Experimental Nanoscience 11:8, pages 619-629.
Read now
Read now
Charles E. Carraher$suffix/text()$suffix/text(), Michael R. Roner, Alisa Moric-Johnson, Lindsey Miller, Girish Barot & Nandalall Sookdeo. (2016) Ability of simple organotin polyethers to inhibit pancreatic cancer. Journal of Macromolecular Science, Part A 53:2, pages 63-71.
Read now
Read now
Xinzhe Yu, Yang Di, Chao Xie, Yunlong Song, Hang He, Hengchao Li, Xinming Pu, Weiyue Lu, Deliang Fu & Chen Jin. (2015) An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line. International Journal of Nanomedicine 10, pages 6825-6834.
Read now
Read now
Tingjie Yin, Lihui Dong, Bei Cui, Lei Wang, Lifang Yin, Jianping Zhou & Meirong Huo. (2015) A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy. International Journal of Nanomedicine 10, pages 7397-7412.
Read now
Read now
Victoria Leonhard, Roxana V Alasino, Ismael D Bianco, Ariel G Garro, Valeria Heredia & Dante M Beltramo. (2015) Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading. International Journal of Nanomedicine 10, pages 3377-3388.
Read now
Read now
Vignesh Narayanan & Colin D Weekes. (2015) Nanoparticle albumin-bound (nab)-paclitaxel for the treatment of pancreas ductal adenocarcinoma. Gastrointestinal Cancer: Targets and Therapy 5, pages 11-19.
Read now
Read now
Roberto A Leon-Ferre & Svetomir N Markovic. (2015) Nab-paclitaxel in patients with metastatic melanoma. Expert Review of Anticancer Therapy 15:12, pages 1371-1377.
Read now
Read now
Darrell Sleep. (2015) Albumin and its application in drug delivery. Expert Opinion on Drug Delivery 12:5, pages 793-812.
Read now
Read now
Si Sun, Lichen Tang, Jian Zhang, Fangfang Lv, Zhonghua Wang, Leiping Wang, Qunling Zhang, Chunlei Zheng, Lixin Qiu, Zhen Jia, Yunhua Lu, Guangyu Liu, Zhimin Shao, Biyun Wang & Xichun Hu. (2014) Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer. International Journal of Nanomedicine 9, pages 1443-1452.
Read now
Read now
Elisa Fontana, Francesco Sclafani & David Cunningham. (2014) Emerging treatments for advanced pancreatic cancer: clinical potential of albumin-bound paclitaxel. Gastrointestinal Cancer: Targets and Therapy 4, pages 89-101.
Read now
Read now
Dustin L Cooper, Christopher M Conder & Sam Harirforoosh. (2014) Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity. Expert Opinion on Drug Delivery 11:10, pages 1661-1680.
Read now
Read now
Sara Cecco, Maria Aliberti, Paolo Baldo, Elisa Giacomin & Roberto Leone. (2014) Safety and efficacy evaluation of albumin-bound paclitaxel
. Expert Opinion on Drug Safety 13:4, pages 511-520.
Read now
Read now
Yan Shi, Rui Qin, Zhi-Kuan Wang & Guang-Hai Dai. (2013) Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma. OncoTargets and Therapy 6, pages 585-591.
Read now
Read now
Carlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, Alessandra Fabi, Sabino De Placido, Grazia Arpino, Paolo Marchetti, Andrea Botticelli, Paolo Pronzato & Elisa Martelli. (2013) An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study. ClinicoEconomics and Outcomes Research 5, pages 125-135.
Read now
Read now
Emilio Alba, Eva Ciruelos, Rafael López, José Manuel López-Vega, Ana Lluch, Miguel Martín, Montserrat Muñoz, Pedro Sánchez-Rovira, Miguel Ángel Seguí, COSTABRAX Working Group, Marta Rubio Liria & Ferran Pérez-Alcántara. (2013) Cost–utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain. Expert Review of Pharmacoeconomics & Outcomes Research 13:3, pages 381-391.
Read now
Read now
Valentina Guarneri, Maria Vittoria Dieci & PierFranco Conte. (2012) Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer. Expert Opinion on Pharmacotherapy 13:3, pages 395-406.
Read now
Read now
Yutaka Yamamoto, Ichiro Kawano & Hirotaka Iwase. (2011) Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval. OncoTargets and Therapy 4, pages 123-136.
Read now
Read now
R Dinarvand, N Sepehri, S Manoochehri, H Rouhani & F Atyabi. (2011) Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. International Journal of Nanomedicine 6, pages 877-895.
Read now
Read now
Dongmei Zhao, Xiuhua Zhao, Yuangang Zu, Jialei Li, Yu Zhang, Ru Jiang & Zhonghua Zhang. (2010) Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. International Journal of Nanomedicine 5, pages 669-677.
Read now
Read now
Elena Neumann, Eva Frei, Dorothee Funk, Matthias D Becker, Hans-Hermann Schrenk, Ulf Müller-Ladner & Christoph Fiehn. (2010) Native albumin for targeted drug delivery. Expert Opinion on Drug Delivery 7:8, pages 915-925.
Read now
Read now
IrshadA. A. Shaikh, Iain Brown, KlausW. J. Wahle & StevenD. Heys. (2010) Enhancing Cytotoxic Therapies for Breast and Prostate Cancers With Polyunsaturated Fatty Acids. Nutrition and Cancer 62:3, pages 284-296.
Read now
Read now
Lifang Wu, Cui Tang & Chunhua Yin. (2010) Folate-mediated solid–liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Development and Industrial Pharmacy 36:4, pages 439-448.
Read now
Read now
M. R. Mozafari, A. Pardakhty, S. Azarmi, J. A. Jazayeri, A. Nokhodchi & A. Omri. (2009) Role of nanocarrier systems in cancer nanotherapy. Journal of Liposome Research 19:4, pages 310-321.
Read now
Read now
R Pamela Mackenzie & A David McCollum. (2009) Novel agents for the treatment of adenocarcinoma of the pancreas. Expert Review of Anticancer Therapy 9:10, pages 1473-1485.
Read now
Read now
Norman S Radin. (2007) Allylic structures in cancer drugs and body metabolites that control cell life and death. Expert Opinion on Drug Discovery 2:6, pages 809-821.
Read now
Read now
Joëlle Dubois. (2006) Recent progress in the development of docetaxel and paclitaxel analogues. Expert Opinion on Therapeutic Patents 16:11, pages 1481-1496.
Read now
Read now
Articles from other publishers (468)
Shoukath Sulthana, Abeera Bhatti, Elza Mathew, Sohel H. Quazi, Natasha N. Gaudreault, Robert DeLong & Santosh Aryal. (2024) Synthetic graphene–copper nanocomposites interact with the hACE-2 enzyme and inhibit its biochemical activity. Nanoscale Advances.
Crossref
Crossref
Gokul Paramasivam, Anandhavelu Sanmugam, Vishnu Vardhan Palem, Murugan Sevanan, Ananda Babu Sairam, Nachiappan Nachiappan, BuHyun Youn, Jung Sub Lee, Muthuchamy Nallal & Kang Hyun Park. (2024) Nanomaterials for detection of biomolecules and delivering therapeutic agents in theragnosis: A review. International Journal of Biological Macromolecules 254, pages 127904.
Crossref
Crossref
Julia S. Passos, Alexsandra C. Apolinario, Kelly Ishida, Tereza S. Martins & Luciana B. Lopes. (2024) Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment. European Journal of Pharmaceutical Sciences 192, pages 106638.
Crossref
Crossref
Annika Adick, Werner Hoheisel, Stefan Schneid, Dennis Mulac, Suna Azhdari & Klaus Langer. (2023) Challenges of nanoparticle albumin bound (nab™) technology: Comparative study of Abraxane® with a newly developed albumin-stabilized itraconazole nanosuspension. European Journal of Pharmaceutics and Biopharmaceutics 193, pages 129-143.
Crossref
Crossref
Siyun Yang & Supratik Kar. (2023) Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity. Artificial Intelligence Chemistry 1:2, pages 100011.
Crossref
Crossref
Sarah Hester, Katja B. Ferenz, Annika Adick, Christos Kakalias, Dennis Mulac, Suna Azhdari & Klaus Langer. (2023) Triglyceride-filled albumin-based nanocapsules: A promising new system to avoid discarding poorly water-soluble drug candidates. International Journal of Pharmaceutics 646, pages 123454.
Crossref
Crossref
Tingxuan Li, Ran Luo, Lina Su, Feng Lv, Lin Mei & Yongkang Yu. (2023) Advanced Materials and Delivery Systems for Enhancement of Chimeric Antigen Receptor Cells. Small Methods 7:11.
Crossref
Crossref
Jonas Kaltbeitzel & Peter R. Wich. (2023) Protein‐based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy. Angewandte Chemie International Edition 62:44.
Crossref
Crossref
Jonas Kaltbeitzel & Peter R. Wich. (2023) Protein‐basierte Nanopartikel: Von Wirkstofftransport zu Bildgebung, Nanokatalyse und Proteintherapie. Angewandte Chemie 135:44.
Crossref
Crossref
James F. Dylewski, George Haddad & Judith Blaine. (2023) Exploiting the neonatal crystallizable fragment receptor to treat kidney disease. Kidney International.
Crossref
Crossref
Pemula Gowtham, Vijaya Anand Arumugam, Karthick Harini, Pragya Pallavi, Anbazhagan Thirumalai, Koyeli Girigoswami & Agnishwar Girigoswami. (2023) Nanostructured proteins for delivering drugs to diseased tissues. Bioinspired, Biomimetic and Nanobiomaterials 12:3, pages 115-129.
Crossref
Crossref
Liu Jinyu, Yanhao Zhang, Chao Liu, Yuhao Jiang, Wang Zihao & Xinsong Li. (2023) Paclitaxel prodrug-encapsulated polypeptide micelles with redox/pH dual responsiveness for cancer chemotherapy. International Journal of Pharmaceutics, pages 123398.
Crossref
Crossref
Adnan Chakra, Naval Singh, Goran T. Vladisavljević, François Nadal, Cécile Cottin-Bizonne, Christophe Pirat & Guido Bolognesi. (2023) Continuous Manipulation and Characterization of Colloidal Beads and Liposomes via Diffusiophoresis in Single- and Double-Junction Microchannels. ACS Nano 17:15, pages 14644-14657.
Crossref
Crossref
Yaru Li, Meiyu Feng, Tao Guo, Zheng Wang & Yanjun Zhao. (2023) Tailored Beta‐Lapachone Nanomedicines for Cancer‐Specific Therapy. Advanced Healthcare Materials 12:20.
Crossref
Crossref
Md Sazzad Hassan, Niranjan Awasthi, Saisantosh Ponna & Urs von Holzen. (2023) Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety. Biomedicines 11:7, pages 2000.
Crossref
Crossref
Yiming Xu, Jessica C. Hsu, Liyun Xu, Weiyu Chen, Weibo Cai & Kai Wang. (2023) Nanomedicine-based adjuvant therapy: a promising solution for lung cancer. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Seyed Hossein Shahcheraghi, Seyed Hadi Shahcheraghi, Marzieh Lotfi, Malihe Lotfi, Seyed Hossein Khaleghinejad, Zara M Tambuwala, Vijay Mishra, Yachana Mishra, Ángel Serrano-Aroca, Alaa A A Aljabali, Mohamed El-Tanani, Gowhar A Naikoo, Sai Raghuveer Chava, Nitin B Charbe, Shivani Bharti, Saravana Kumar Jaganathan, Rohit Goyal, Poonam Negi, Murtaza M Tambuwala & Oladipo Folorunso. (2023) Photonic nanoparticles: emerging theranostics in cancer treatment. Therapeutic Delivery.
Crossref
Crossref
Nicoletta Colombo, Toon Van Gorp, Ursula A. Matulonis, Ana Oaknin, Rachel N. Grisham, Gini F. Fleming, Alexander B. Olawaiye, Dorothy D. Nguyen, Andrew E. Greenstein, Joseph M. Custodio, Hristina I. Pashova, Iulia C. Tudor & Domenica Lorusso. (2023) Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study. Journal of Clinical Oncology.
Crossref
Crossref
Boyang Sun, Shuai Shao, Sanjana Ghosh, Jiexin Li, Xiaojie Wang, Changning Li, Breandan Quinn, Paschalis Alexandridis, Jonathan F. Lovell & Yumiao Zhang. (2023) Facile preparation of cabazitaxel-loaded nanoparticles directly lyophilized from dioxane一种用二氧六环制备紫杉醇冻干制剂的简易方法. Science China Materials 66:6, pages 2513-2522.
Crossref
Crossref
Yogesh Dutt, Ramendra Pati Pandey, Mamta Dutt, Archana Gupta, Arpana Vibhuti, Jasmina Vidic, V. Samuel Raj, Chung-Ming Chang & Anjali Priyadarshini. (2023) Therapeutic applications of nanobiotechnology. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Yanhao Zhang, Hao Zhang, Ji Wang, Chao Liu, Hanlei Xing, Yuhao Jiang & Xinsong Li. (2023) Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy. Molecular Pharmaceutics 20:5, pages 2513-2526.
Crossref
Crossref
Brijendra Kumar Kashyap, Virendra Vikram Singh, Manoj Kumar Solanki, Anil Kumar, Janne Ruokolainen & Kavindra Kumar Kesari. (2023) Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities. ACS Omega 8:16, pages 14290-14320.
Crossref
Crossref
Yuetong Liu, Ge Hong, Lina Mao, Zhe Su, Tianjun Liu & Hong Liu. (2023) A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy. Molecules 28:9, pages 3662.
Crossref
Crossref
Wenjie Shi, Xinyu Wan, Ye Wang, Jinzhi He, Xiaofeng Huang, Yinggang Xu, Weiwei Zhang, Rui Chen, Lexin Wang, Ran Zheng, Lingjun Ma, Xuan Li, Lu Xu, Xiaoming Zha & Jue Wang. (2023) Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer. Nanomedicine: Nanotechnology, Biology and Medicine 49, pages 102666.
Crossref
Crossref
Vaibhavi Srivastava, Padakanti Sandeep Chary, Naveen Rajana, Ekta R. Pardhi, Vivek Singh, Dharmendra Khatri, Shashi Bala Singh & Neelesh Kumar Mehra. (2023) Complex ophthalmic formulation technologies: Advancement and future perspectives. Journal of Drug Delivery Science and Technology 82, pages 104317.
Crossref
Crossref
Mengran Zhang, Huaqing Chen, Wenlong Zhang, Yan Liu, Liuyan Ding, Junwei Gong, Runfang Ma, Shaohui Zheng & Yunlong Zhang. (2023) Biomimetic Remodeling of Microglial Riboflavin Metabolism Ameliorates Cognitive Impairment by Modulating Neuroinflammation. Advanced Science 10:12.
Crossref
Crossref
Jinu Mathew, Pallav Namdeo & Ashish Garg. 2023. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective
349
381
.
Alessia Marconi, Edoardo Jun Mattioli, Filippo Ingargiola, Giulia Giugliano, Tainah Dorina Marforio, Luca Prodi, Matteo Di Giosia & Matteo Calvaresi. (2023) Dissecting the Interactions between Chlorin e6 and Human Serum Albumin. Molecules 28:5, pages 2348.
Crossref
Crossref
Madhusmita Bhuyan, Malkiet Kaur, Udesh Kaushal, Manju Nagpal, Manjinder Singh & Geeta Aggarwal. (2023) Recent Avenues in Treatment of Liver Diseases: Role of Nanotechnology. Current Drug Targets 24:4, pages 320-331.
Crossref
Crossref
Nuphar Veiga, Yael Diesendruck & Dan Peer. (2023) Targeted nanomedicine: Lessons learned and future directions. Journal of Controlled Release 355, pages 446-457.
Crossref
Crossref
Yanhao Zhang, Ji Wang, Hanlei Xing, Chao Liu & Xinsong Li. (2023) Redox-responsive paclitaxel-pentadecanoic acid conjugate encapsulated human serum albumin nanoparticles for cancer therapy. International Journal of Pharmaceutics 635, pages 122761.
Crossref
Crossref
Zhengxing Su, Jinlong Zhao, Xi Zhao, Jia Xie, Ming Li & Dong Zhao. (2023) Preclinical evaluation of albumin-bound docetaxel nanoparticles as potential anti-cancer products. International Journal of Pharmaceutics 635, pages 122711.
Crossref
Crossref
Sonali Mohanty, Sikta Panda, U. Devadharshini & Subhankar Paul. (2023) Proteins and their functionalization for finding therapeutic avenues in cancer: Current status and future prospective. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:2, pages 188862.
Crossref
Crossref
Anindita Dhara, Shourya Majumder, Srijoni Pahari & Debasish Kar. (2023) Improved Targeting of Therapeutics by Nanocarrier-Based Delivery in Cancer Immunotherapy and Their Future Perspectives. BioNanoScience 13:1, pages 278-299.
Crossref
Crossref
Gabriela Bordeianu, Nina Filip, Andrei Cernomaz, Bogdan Veliceasa, Loredana Liliana Hurjui, Alin Constantin Pinzariu, Mihaela Pertea, Andreea Clim, Mihai Vasile Marinca & Ionela Lacramioara Serban. (2023) The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer. Biomedicines 11:3, pages 705.
Crossref
Crossref
Giuseppe Galletti & Paraskevi Giannakakou. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
18
.
Lijun Zhu, Yu Li, Mou Jiang, Changsheng Ke, Hanxiong Long, Maosong Qiu, Lei Zhang, Chaohui Ye, Xin Zhou, Zhong-Xing Jiang & Shizhen Chen. (2023) Self-Assembly of Precisely Fluorinated Albumin for Dual Imaging-Guided Synergistic Chemo–Photothermal–Photodynamic Cancer Therapy. ACS Applied Materials & Interfaces 15:2, pages 2665-2678.
Crossref
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer
7
159
.
Dipayan Roy, Anupama Modi, Ritwik Ghosh & Julián Benito-León. 2023. Antiviral and Antimicrobial Coatings Based on Functionalized Nanomaterials. Antiviral and Antimicrobial Coatings Based on Functionalized Nanomaterials
447
484
.
Sindhu C. Pillai, Athira Anirudhan & D. Sakthi Kumar. 2023. Biomedical Applications and Toxicity of Nanomaterials. Biomedical Applications and Toxicity of Nanomaterials
129
154
.
Gordon Winter, Nina Eberhardt, Jessica Löffler, Marco Raabe, Md. Noor A. Alam, Li Hao, Alireza Abaei, Hendrik Herrmann, Claudia Kuntner, Gerhard Glatting, Christoph Solbach, Fedor Jelezko, Tanja Weil, Ambros J. Beer & Volker Rasche. (2022) Preclinical PET and MR Evaluation of 89Zr- and 68Ga-Labeled Nanodiamonds in Mice over Different Time Scales. Nanomaterials 12:24, pages 4471.
Crossref
Crossref
Xing Li, Lingpu Zhang, Tuo Li, Shumu Li, Wenjing Wu, Lingyu Zhao, Peng Xie, Jinqi Yang, Peipei Li, Yangyang Zhang, Haihua Xiao, Yingjie Yu & Zhenwen Zhao. (2022) Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Lingyun Zhang, Jiayu Zhang, Yan Wang, Wei Li, Shan Yu, Qian Li, Yiyi Yu, Tianshu Liu & Yuehong Cui. (2022) Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study. BMC Gastroenterology 22:1.
Crossref
Crossref
Olivia Cano-Garrido, Naroa Serna, Ugutz Unzueta, Eloi Parladé, Ramón Mangues, Antonio Villaverde & Esther Vázquez. (2022) Protein scaffolds in human clinics. Biotechnology Advances 61, pages 108032.
Crossref
Crossref
Maria C. Spera, Maria C. Cesta, Mara Zippoli, Giustino Varrassi & Marcello Allegretti. (2022) Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis. Pain and Therapy 11:4, pages 1113-1136.
Crossref
Crossref
Qianling Ye, Yun Lin, Ruihao Li, Huaiji Wang & Chunyan Dong. (2022) Recent advances of nanodrug delivery system in the treatment of hematologic malignancies. Seminars in Cancer Biology 86, pages 607-623.
Crossref
Crossref
Eugene J. Koay, Mohamed Zaid, Maureen Aliru, Polycarpe Bagereka, Arie Van Wieren, Maria Jovie Rodriguez, Galia Jacobson, Robert A. Wolff, Michael Overman, Gauri Varadhachary, Shubham Pant, Huamin Wang, Ching-Wei Tzeng, Naruhiko Ikoma, Michael Kim, Jeffrey E. Lee, Matthew HG. Katz, Eric Tamm, Priya Bhosale, Cullen M. Taniguchi, Emma B. Holliday, Grace L. Smith, Ethan B. Ludmir, Bruce D. Minsky, Christopher H. Crane, Albert C. Koong, Prajnan Das, Xuemei Wang, Milind Javle & Sunil Krishnan. (2022) Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation. International Journal of Radiation Oncology*Biology*Physics 114:3, pages 444-453.
Crossref
Crossref
Juanjuan Yang, Xiaojin Wang, Bingshun Wang, Kinam Park, Karen Wooley & Shiyi Zhang. (2022) Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers. Advanced Drug Delivery Reviews 190, pages 114525.
Crossref
Crossref
Zhaoyi Li, Keyuan Chen, Peter Rose & Yi Zhun Zhu. (2022) Natural products in drug discovery and development: Synthesis and medicinal perspective of leonurine. Frontiers in Chemistry 10.
Crossref
Crossref
Søren Brøgger Christensen. (2022) Drugs That Changed Society: Microtubule-Targeting Agents Belonging to Taxanoids, Macrolides and Non-Ribosomal Peptides. Molecules 27:17, pages 5648.
Crossref
Crossref
Seth-Frerich Fobian, Melissa Petzer, Melissa Vetten, Vanessa Steenkamp, Mary Gulumian & Werner Cordier. (2022) Mechanisms facilitating the uptake of carboxyl–polythene glycol-functionalized gold nanoparticles into multicellular spheroids. Journal of Pharmacy and Pharmacology 74:9, pages 1282-1295.
Crossref
Crossref
Rodrigo dos A. Miguel, Amanda S. Hirata, Paula C. Jimenez, Luciana B. Lopes & Leticia V. Costa-Lotufo. (2022) Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs. Pharmaceutics 14:8, pages 1722.
Crossref
Crossref
Fei He, Jiaxuan Liu, Xin Shen, Zijing Wang, Qiao Li & Guohui Li. (2021) Adverse Event Profile for Nanoparticle Albumin-Bound Paclitaxel Compared With Solvent-Based Taxanes in Solid-Organ Tumors: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Annals of Pharmacotherapy 56:8, pages 898-909.
Crossref
Crossref
Sopee Poomsawat, Theerachai Kosanwat, Ounruean Meesakul & Sirima Sanguansin. (2022) Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 134:2, pages e44-e50.
Crossref
Crossref
Linlin Sun, Pan Zhao, Menghan Chen, Jiayi Leng, Yixin Luan, Baoxiang Du, Jia Yang, Yong Yang & Rong Rong. (2022) Taxanes prodrug-based nanomedicines for cancer therapy. Journal of Controlled Release 348, pages 672-691.
Crossref
Crossref
Yi Yang, Xiangliang Liu, Wei Song, Jin Lu, Na Yin, Xiaojun Ye & Xiao Chen. (2022) Case Report: First-Line Immunotherapy for Esophageal Squamous Carcinoma Combined With Hypopharyngeal Squamous Carcinoma Yields Sustained Survival Benefit. Frontiers in Immunology 13.
Crossref
Crossref
Konstantina Matskou, Berke Kisaoglan, Barbara Mavroidi, Maria Pelecanou, Maria Zoumpanioti, Ilias Matis & Aristotelis Xenakis. (2022) Inducing the formation of a colloidal albumin carrier of curcumin. JCIS Open 6, pages 100051.
Crossref
Crossref
Michele Aventaggiato, Federica Barreca, Luigi Sansone, Laura Pellegrini, Matteo A. Russo, Marco Cordani & Marco Tafani. (2022) Sirtuins and Hypoxia in EMT Control. Pharmaceuticals 15:6, pages 737.
Crossref
Crossref
Xu Cao, Yingyu Wang, Wencan Zhang, Xiancai Zhong, E. Gulsen Gunes, Jessica Dang, Jinhui Wang, Alan L. Epstein, Christiane Querfeld, Zuoming Sun, Steven T. Rosen & Mingye Feng. (2022) Targeting macrophages for enhancing CD47 blockade–elicited lymphoma clearance and overcoming tumor-induced immunosuppression. Blood 139:22, pages 3290-3302.
Crossref
Crossref
Wenwen Wang, Jing Cai, Jiayi Wen, Xinyi Li, Yingjie Yu, Lingpu Zhang, Qing Han, Zheng Wei, Yujia Ma, Feiquan Ying, Xiaohan Xu, Wenhan Li, Qiang Yang, Si Sun, Xiaoqi He, Liqiong Cai, Haihua Xiao & Zehua Wang. (2022) Boosting ferroptosis via abplatin(iv) for treatment of platinum-resistant recurrent ovarian cancer. Nano Today 44, pages 101459.
Crossref
Crossref
Sheema Hashem, Tayyiba Akbar Ali, Sabah Akhtar, Sabah Nisar, Geetanjali Sageena, Shahid Ali, Sharefa Al-Mannai, Lubna Therachiyil, Rashid Mir, Imadeldin Elfaki, Mohammad Muzaffar Mir, Farrukh Jamal, Tariq Masoodi, Shahab Uddin, Mayank Singh, Mohammad Haris, Muzafar Macha & Ajaz A. Bhat. (2022) Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomedicine & Pharmacotherapy 150, pages 113054.
Crossref
Crossref
Yuru Tong, Yunfeng F Luo & Wei Gao. (2021) Biosynthesis of paclitaxel using synthetic biology. Phytochemistry Reviews 21:3, pages 863-877.
Crossref
Crossref
Hye Gyeong Yang, Eun‐Ju Yang, Eun Ji Park, Young Jin Lee, Maryam Sadat Safavi, Kyung‐Sik Song & Dong Hee Na. (2022)
Synthesis and characterization of
β‐carotene‐loaded
albumin nanoparticles by
high‐speed
homogenizer
. Bulletin of the Korean Chemical Society 43:5, pages 677-685.
Crossref
Crossref
Cai Yang, Haitao Zhao, Yang Sun, Cheng Wang, Xinyao Geng, Ruowen Wang, Lumin Tang, Da Han, Jianjun Liu & Weihong Tan. (2022) Programmable manipulation of oligonucleotide–albumin interaction for elongated circulation time. Nucleic Acids Research 50:6, pages 3083-3095.
Crossref
Crossref
Weiwei Zhang, Yinggang Xu, Xiaoqing Shi, Xiaofeng Huang, Rui Chen, Haiping Xu, Wenjie Shi, Xinyu Wan, Ye Wang, Jinzhi He, Cuiying Li, Jue Wang & Xiaoming Zha. (2022) Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer. Nanomedicine 17:10, pages 683-694.
Crossref
Crossref
Akihisa Kato, Itaru Naitoh, Aya Naiki-Ito, Kazuki Hayashi, Fumihiro Okumura, Yasuaki Fujita, Hitoshi Sano, Yuji Nishi, Katsuyuki Miyabe, Tadahisa Inoue, Atsuyuki Hirano, Hiroki Takada, Michihiro Yoshida, Yasuki Hori, Makoto Natsume, Hiroyuki Kato, Satoru Takahashi & Hiromi Kataoka. (2022) Class III β-Tubulin Expression Is of Value in Selecting nab-Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer. Pancreas 51:4, pages 372-379.
Crossref
Crossref
Hirohito Seki, Kaori Higeta, Takashi Sakurai, Akihisa Sakurada, Tetsuhiko Kinoshita & Ken Shimizu. (2022) Feasibility Study of Nanoparticle Albumin-Bound-Paclitaxel and S-1 Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer: A Prospective Study. Clinical Breast Cancer 22:3, pages 235-243.
Crossref
Crossref
Yumna Zaheer, Thomas Vorup‐Jensen, Thomas J. Webster, Mukhtiar Ahmed, Waheed S. Khan & Ayesha Ihsan. (2021) Protein based nanomedicine: Promising therapeutic modalities against inflammatory disorders. Nano Select 3:4, pages 733-750.
Crossref
Crossref
Qi Chen, Chengfang Xu, Zhonghao Sun, Jingjing Yang, Fan Chen, Zixiang Lin, Degui Lin, Yanyan Jiang & Jiahao Lin. (2022) Development of S4A–BSA–Au NPs for enhanced anti-tumor therapy of canine breast cancer. Nanoscale Advances 4:7, pages 1808-1814.
Crossref
Crossref
Hanhee Cho, Seong Ik Jeon, Cheol-Hee Ahn, Man Kyu Shim & Kwangmeyung Kim. (2022) Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation. Pharmaceutics 14:4, pages 728.
Crossref
Crossref
Kuan-Jung Chiu, Hsin-Ying Clair Chiou, Chi-Han Huang, Pin-Chun Lu, Hui-Ru Kuo, Jiunn-Wei Wang & Ming-Hong Lin. (2022) Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights. Biomedicines 10:3, pages 713.
Crossref
Crossref
Xu Cao, Jing Chen, Bolei Li, Jessica DangWencan ZhangXiancai Zhong, Chongkai Wang, Mustafa Raoof, Zuoming Sun, Jianhua Yu, Marwan G. Fakih & Mingye Feng. (2022) Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy. Science Advances 8:11.
Crossref
Crossref
Nahal Habibi, Ava Mauser, Jeffery E Raymond & Joerg Lahann. (2022) Systematic studies into uniform synthetic protein nanoparticles. Beilstein Journal of Nanotechnology 13, pages 274-283.
Crossref
Crossref
Akiko Takahashi, Rintaro Noro, Natsuki Takano, Kakeru Hisakane, Satoshi Takahashi, Aya Fukuizumi, Miwako Omori, Teppei Sugano, Susumu Takeuchi, Shinji Nakamichi, Akihiko Miyanaga, Yuji Minegishi, Kaoru Kubota, Masahiro Seike & Akihiko Gemma. (2022) Carboplatin plus nanoparticle albumin‑bound paclitaxel for the treatment of thymic carcinoma. Molecular and Clinical Oncology 16:4.
Crossref
Crossref
Razan Haddad, Nasr Alrabadi, Bashar Altaani & Tonglei Li. (2022) Paclitaxel Drug Delivery Systems: Focus on Nanocrystals’ Surface Modifications. Polymers 14:4, pages 658.
Crossref
Crossref
Diala Merheb, Georgette Dib, Maroun Bou Zerdan, Clara El Nakib, Saada Alame & Hazem I. Assi. (2022) Drug-Induced Peripheral Neuropathy: Diagnosis and Management. Current Cancer Drug Targets 22:1, pages 49-76.
Crossref
Crossref
Sajid Iqbal & Zhongxi Zhao. (2022) Poly (β amino esters) copolymers: Novel potential vectors for delivery of genes and related therapeutics. International Journal of Pharmaceutics 611, pages 121289.
Crossref
Crossref
Sunil Kumar Dubey, Tanya Bhatt, Mukta Agrawal, Ranendra Narayan Saha, Swarnlata Saraf, Shailendra Saraf & Amit Alexander. (2022) Application of chitosan modified nanocarriers in breast cancer. International Journal of Biological Macromolecules 194, pages 521-538.
Crossref
Crossref
Prachi Ghoderao, Sanjay Sahare, Anjali A. Kulkarni & Tejashree Bhave. 2022. Paclitaxel. Paclitaxel
309
331
.
Joseph L. GravesJr.Jr.. 2022. Principles and Applications of Antimicrobial Nanomaterials. Principles and Applications of Antimicrobial Nanomaterials
217
233
.
Chrysafis Andreou, Yiota Gregoriou, Akbar Ali & Suchetan Pal. 2022. SERS for Point-Of-care and Clinical Applications. SERS for Point-Of-care and Clinical Applications
199
235
.
Aman Bajpai, Sopan Shinde & Sudipta Basu. 2022. Nanotechnology in Medicine and Biology. Nanotechnology in Medicine and Biology
25
56
.
Prateek Srivastava, Sumit Kumar Hira & Partha Pratim Manna. 2022. 2D Nanomaterials for Energy and Environmental Sustainability. 2D Nanomaterials for Energy and Environmental Sustainability
197
221
.
Ignacio Rivero Berti & Guillermo R. Castro. 2022. Micro- and Nano-containers for Smart Applications. Micro- and Nano-containers for Smart Applications
79
103
.
Asma Musfira Shabbirahmed, Mohanya Kumaravel, Prathap Somu, Subhankar Paul & Anjul Khadria. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1261
1284
.
Asma Musfira Shabbirahmed, Mohanya Kumaravel, Prathap Somu, Subhankar Paul & Anjul Khadria. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
24
.
Asma Musfira Shabbirahmed, Mohanya Kumaravel, Prathap Somu, Subhankar Paul & Anjul Khadria. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
24
.
Rudradip Das, Hansal Kumar, Asmita Choithramani, Gourav Bothra & Amit Shard. 2022. Polymeric nanoparticles for the treatment of solid tumors. Polymeric nanoparticles for the treatment of solid tumors
167
211
.
Zhiqi Zhang & Kyle J. Lampe. 2022. Engineering Biomaterials for Neural Applications. Engineering Biomaterials for Neural Applications
259
305
.
Jessica E. Holder, Minnatallah Al-Yozbaki & Cornelia M. Wilson. 2023. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer
1093
1110
.
Andrew Gould, Daniel Zhang, Víctor A. Arrieta, Roger Stupp & Adam M. Sonabend. (2021) Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas. Oncotarget 12:25, pages 2474-2475.
Crossref
Crossref
Jun Ye, Renjie Li, Yanfang Yang, Wujun Dong, Yujie Wang, Hongliang Wang, Tong Sun, Lin Li, Qiqi Shen, Caiyun Qin, Xiaoyan Xu, Hengfeng Liao, Yiqun Jin, Xuejun Xia & Yuling Liu. (2021) Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Humzah Jamshaid, Fakhar ud Din & Gul Majid Khan. (2021) Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Abdallah Ladaycia, Catherine Passirani & Elise Lepeltier. (2021) Microbiota and nanoparticles: Description and interactions. European Journal of Pharmaceutics and Biopharmaceutics 169, pages 220-240.
Crossref
Crossref
Marc-Phillip Mast, Harshvardhan Modh, Carole Champanhac, Jiong-Wei Wang, Gerrit Storm, Johannes Krämer, Volker Mailänder, Giorgia Pastorin & Matthias G. Wacker. (2021) Nanomedicine at the crossroads – A quick guide for IVIVC. Advanced Drug Delivery Reviews 179, pages 113829.
Crossref
Crossref
Huan Zhang, Jinshun Xu, Binyang Gao, Hong Wang, Jianbo Huang, Jie Zhou, Rui Yang, Feng Yan & Yulan Peng. (2021) Synergistic Cascade Strategy Based on Modifying Tumor Microenvironment for Enhanced Breast Cancer Therapy. Frontiers in Pharmacology 12.
Crossref
Crossref
Laura Raquel Comini, Roxana Valeria Alasino, Victoria Leonhard, Karina Lilian Bierbrauer & Dante Miguel Beltramo. (2021) Self-assembled micelles of the (lipo) glycopeptides, teicoplanin, as taxane nanocarriers. Nanotechnology 32:46, pages 465102.
Crossref
Crossref
Qingxin Mu, Guanyou Lin, Mike Jeon, Hui Wang, Fei-Chien Chang, Richard A. Revia, John Yu & Miqin Zhang. (2021) Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer. Materials Today 50, pages 149-169.
Crossref
Crossref
Duhyeong Hwang, Natasha Vinod, Sarah L. Skoczen, Jacob D. Ramsey, Kelsie S. Snapp, Stephanie A. Montgomery, Mengzhe Wang, Chaemin Lim, Jonathan E. Frank, Marina Sokolsky-Papkov, Zibo Li, Hong Yuan, Stephan T. Stern & Alexander V. Kabanov. (2021) Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay. Biomaterials 278, pages 121140.
Crossref
Crossref
Yuezhou Zhang, Huaguang Cui, Ruiqi Zhang, Hongbo Zhang & Wei Huang. (2021) Nanoparticulation of Prodrug into Medicines for Cancer Therapy. Advanced Science 8:18.
Crossref
Crossref
Chaw Yee Beh, Ray Putra Prajnamitra, Li-Lun Chen & Patrick Ching-Ho Hsieh. (2021) Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis. Molecules 26:16, pages 5052.
Crossref
Crossref
Daniel R. Principe, Patrick W. Underwood, Murray Korc, Jose G. Trevino, Hidayatullah G. Munshi & Ajay Rana. (2021) The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy. Frontiers in Oncology 11.
Crossref
Crossref
Jianping Liu, Kai Liu, Liming Zhang, Ming Zhong, Tingliang Hong, Run Zhang, Yufan Gao, Rui Li, Tiefeng Xu & Zhi Ping Xu. (2021) Heat/pH-boosted release of 5-fluorouracil and albumin-bound paclitaxel from Cu-doped layered double hydroxide nanomedicine for synergistical chemo-photo-therapy of breast cancer. Journal of Controlled Release 335, pages 49-58.
Crossref
Crossref
Irene C. Jenkins, Joshua J. Milligan & Ashutosh Chilkoti. (2021) Genetically Encoded Elastin‐Like Polypeptides for Drug Delivery. Advanced Healthcare Materials 10:13.
Crossref
Crossref
Chi-Ling Chiang, Ming-Huei Cheng & Chih-Hsin Lin. (2021) From Nanoparticles to Cancer Nanomedicine: Old Problems with New Solutions. Nanomaterials 11:7, pages 1727.
Crossref
Crossref
Harold W Davis, Ahmet Kaynak, Subrahmanya D Vallabhapurapu & Xiaoyang Qi. (2021) Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer. World Journal of Gastrointestinal Oncology 13:6, pages 550-559.
Crossref
Crossref
Jing Wang, Yiye Li & Guangjun Nie. (2021) Multifunctional biomolecule nanostructures for cancer therapy. Nature Reviews Materials 6:9, pages 766-783.
Crossref
Crossref
Alessandra Spada, Jaber Emami, Jack A. Tuszynski & Afsaneh Lavasanifar. (2021) The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. Molecular Pharmaceutics 18:5, pages 1862-1894.
Crossref
Crossref
Donald J. AbrahamMallory Pullman, Francisco León & Stephen J. Cutler. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
89
.
Shariq Ali, Norah A. Albekairi, Sanaalarab Al-Enazy, Mansi Shah, Svetlana Patrikeeva, Tatiana N. Nanovskaya, Mahmoud S. Ahmed & Erik Rytting. (2021) Formulation effects on paclitaxel transfer and uptake in the human placenta. Nanomedicine: Nanotechnology, Biology and Medicine 33, pages 102354.
Crossref
Crossref
Yongchao Wang, Jinjin Wang, Dandan Zhu, Yufei Wang, Guangchao Qing, Yuxuan Zhang, Xiaoxuan Liu & Xing-Jie Liang. (2021) Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies. Acta Pharmaceutica Sinica B 11:4, pages 886-902.
Crossref
Crossref
Yimeng Chen, Baoshi Bao, Yao Lv, Decong Sun, Li Zhang, Jiandong Wang & Weihong Zhao. (2020) Nab-paclitaxel-based regimens with docetaxel-based regimens as neoadjuvant treatment for early breast cancer. Investigational New Drugs 39:2, pages 524-529.
Crossref
Crossref
Silvia Voci, Agnese Gagliardi, Roberto Molinaro, Massimo Fresta & Donato Cosco. (2021) Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels. Gels 7:2, pages 33.
Crossref
Crossref
Weihua Chen, Zhen Sun & Lehui Lu. (2020) Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives. Angewandte Chemie International Edition 60:11, pages 5626-5643.
Crossref
Crossref
Weihua Chen, Zhen Sun & Lehui Lu. (2020) Zielgerichtete Wirkstoffe für die Krebstherapie: Aktuelle Entwicklungen und Perspektiven. Angewandte Chemie 133:11, pages 5686-5705.
Crossref
Crossref
Mohammad Azam Ansari, Muthu Thiruvengadam, Zeba Farooqui, Govindaswamy Rajakumar, Qazi Mohammad Sajid Jamal, Mohammad A. Alzohairy, Ahmad Almatroudi, Mohammad N. Alomary, Ill-Min Chung & Ebtesam Abdullah Al-Suhaimi. (2021) Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer. Seminars in Cancer Biology 69, pages 109-128.
Crossref
Crossref
Mohammad Norouzi & Pierre Hardy. (2021) Clinical applications of nanomedicines in lung cancer treatment. Acta Biomaterialia 121, pages 134-142.
Crossref
Crossref
Min Huang, Jin-Jian Lu & Jian Ding. (2021) Natural Products in Cancer Therapy: Past, Present and Future. Natural Products and Bioprospecting 11:1, pages 5-13.
Crossref
Crossref
Nianwu Wang, Wei Wang, Wenli Mao, Kefeng Wang, Haozhe Zhang, Qiang Ma, Nazuke Kuerbantayi & Yukun Wang. (2021) New Approved First-line Combining Therapy of NSCLC in 2020. E3S Web of Conferences 245, pages 03057.
Crossref
Crossref
Alice Boilève, Marc Hilmi, Paul Gougis, Romain Cohen, Benoît Rousseau, Jean-Frédéric Blanc, Meher Ben Abdelghani, Hélène Castanié, Laëtitia Dahan, David Tougeron, Jean-Philippe Metges, Christophe Tournigand, Marie-Line Garcia-Larnicol, Dewi Vernerey, Anthony Turpin & Cindy Neuzillet. (2021) Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial. European Journal of Cancer 143, pages 55-63.
Crossref
Crossref
Luciana Mosca, Andrea Ilari, Francesco Fazi, Yehuda G. Assaraf & Gianni Colotti. (2021) Taxanes in cancer treatment: Activity, chemoresistance and its overcoming. Drug Resistance Updates 54, pages 100742.
Crossref
Crossref
Manzar Abbas, Muhammad Ovais, Sudip Mukherjee, Arbab Ali, Muhammad Hanif & Chunying Chen. 2021. Biogenic Nanoparticles for Cancer Theranostics. Biogenic Nanoparticles for Cancer Theranostics
1
26
.
Mamoon Rashid & Mehbuba Rahman. 2021. Bioinspired and Biomimetic Materials for Drug Delivery. Bioinspired and Biomimetic Materials for Drug Delivery
1
14
.
Awais Ahmad, Ikram Ahmad, Anish Khan, Muhammad Abdullah, Ching Yern Chee & Francis Verpoort. 2021. Nanomedicine Manufacturing and Applications. Nanomedicine Manufacturing and Applications
1
20
.
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy
351
371
.
Charles Oluwaseun Adetunji, Abel Inobeme, Olugbemi Tope Olaniyan, Olulope Olufemi Ajayi, Seyi Olaniyan & Juliana Bunmi Adetunji. 2021. Medicinal Plants for Lung Diseases. Medicinal Plants for Lung Diseases
609
622
.
E. A. Adebayo, I. C. Oladipo, J. A. Badmus & A. Lateef. 2021. Microbial Nanobiotechnology. Microbial Nanobiotechnology
315
342
.
Megala Jayaraman, Parijat Dutta, Jayesh Telang & Sabari Krishnan B. B.. 2021. Nanomedicine for Cancer Diagnosis and Therapy. Nanomedicine for Cancer Diagnosis and Therapy
1
45
.
Layla Mohammad-Hadi & Marym Mohammad-HadiLayla Mohammad-Hadi & Marym Mohammad-Hadi. 2021. Applications of Minimally Invasive Nanomedicine-Based Therapies in 3D in vitro Cancer Platforms. Applications of Minimally Invasive Nanomedicine-Based Therapies in 3D in vitro Cancer Platforms
41
69
.
Layla Mohammad-Hadi & Marym Mohammad-Hadi. 2021. Applications of Minimally Invasive Nanomedicine-Based Therapies in 3D in vitro Cancer Platforms. Applications of Minimally Invasive Nanomedicine-Based Therapies in 3D in vitro Cancer Platforms.
Kenro Hirata, Yasuo Hamamoto, Masahiko Ando, Chiyo K. Imamura, Kenichi Yoshimura, Kentaro Yamazaki, Shuichi Hironaka & Kei Muro. (2020) Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group. BMC Cancer 20:1.
Crossref
Crossref
Caroline Mari Ramos Oda, Juliana de Oliveira Silva, Renata Salgado Fernandes, Alysson Vinícius Braga, Renes de Resende Machado, Márcio de Matos Coelho, Geovanni Dantas Cassali, Diego Carlos Reis, André Luís Branco de Barros & Elaine Amaral Leite. (2020) Encapsulating paclitaxel in polymeric nanomicelles increases antitumor activity and prevents peripheral neuropathy. Biomedicine & Pharmacotherapy 132, pages 110864.
Crossref
Crossref
Vito Lorusso, Agnese Latorre & Francesco Giotta. (2020) Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer. Journal of Oncology 2020, pages 1-17.
Crossref
Crossref
Kanchan Chauhan, Prakhar Sengar, Karla Juarez-Moreno, Gustavo A. Hirata & Rafael Vazquez-Duhalt. (2020) Camouflaged, activatable and therapeutic tandem bionanoreactors for breast cancer theranosis. Journal of Colloid and Interface Science 580, pages 365-376.
Crossref
Crossref
Alexandre Pérez-López, Cristina Martín-Sabroso, Ana Isabel Torres-Suárez & Juan Aparicio-Blanco. (2020) Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom. Pharmaceutics 12:11, pages 1028.
Crossref
Crossref
Parinaz Sabourian, Ghazaleh Yazdani, Seyed Sajad Ashraf, Masoud Frounchi, Shohreh Mashayekhan, Sahar Kiani & Ashok Kakkar. (2020) Effect of Physico-Chemical Properties of Nanoparticles on Their Intracellular Uptake. International Journal of Molecular Sciences 21:21, pages 8019.
Crossref
Crossref
Jesse Yu, Qingxin Mu, Simone Perazzolo, James I Griffin, Linxi Zhu, Lisa A McConnachie, Danny D Shen & Rodney JY Ho. (2020) Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer Nodules. Pharmaceutical Research 37:10.
Crossref
Crossref
Qingxin Mu, Guanyou Lin, Zachary R. Stephen, Seokhwan Chung, Hui Wang, Victoria K. Patton, Rachel N. Gebhart & Miqin Zhang. (2020) In vivo serum enabled production of ultrafine nanotherapeutics for cancer treatment. Materials Today 38, pages 10-23.
Crossref
Crossref
Yang Shi. (2020) Clinical Translation of Nanomedicine and Biomaterials for Cancer Immunotherapy: Progress and Perspectives. Advanced Therapeutics 3:9.
Crossref
Crossref
Min Sung Suh, Sharadrao M. Patil, Darby Kozak, Eric Pang, Stephanie Choi, Xiaohui Jiang, Jason D. Rodriguez, David A. Keire & Kang Chen. (2020) An NMR Protocol for In Vitro Paclitaxel Release from an Albumin-Bound Nanoparticle Formulation. AAPS PharmSciTech 21:5.
Crossref
Crossref
Hèctor López‐Laguna, Laura Sánchez‐García, Naroa Serna, Eric Voltà‐Durán, Julieta M. Sánchez, Alejandro Sánchez‐Chardi, Ugutz Unzueta, Marcin Łoś, Antonio Villaverde & Esther Vázquez. (2020) Engineering Protein Nanoparticles Out from Components of the Human Microbiome. Small 16:30.
Crossref
Crossref
Kristel C. Tjandra, Chelsea R. Forest, Chin Ken Wong, Sheilajen Alcantara, Hannah G. Kelly, Yi Ju, Martina H. Stenzel, Joshua A. McCarroll, Maria Kavallaris, Frank Caruso, Stephen J. Kent & Pall Thordarson. (2020) Modulating the Selectivity and Stealth Properties of Ellipsoidal Polymersomes through a Multivalent Peptide Ligand Display. Advanced Healthcare Materials 9:13.
Crossref
Crossref
Rabah Gahoual, Gérard Bolbach, Ikram Ould-Melha, Gilles Clodic, Yannis-Nicolas François, Daniel Scherman, Nathalie Mignet & Pascal Houzé. (2020) Kinetic and structural characterization of therapeutic albumin chemical functionalization using complementary mass spectrometry techniques. Journal of Pharmaceutical and Biomedical Analysis 185, pages 113242.
Crossref
Crossref
Josef Gillson, Yogambha Ramaswamy, Gurvinder Singh, Alemayehu A. Gorfe, Nick Pavlakis, Jaswinder Samra, Anubhav Mittal & Sumit Sahni. (2020) Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?. Cancers 12:5, pages 1341.
Crossref
Crossref
Abuzer Alp Yetisgin, Sibel Cetinel, Merve Zuvin, Ali Kosar & Ozlem Kutlu. (2020) Therapeutic Nanoparticles and Their Targeted Delivery Applications. Molecules 25:9, pages 2193.
Crossref
Crossref
Qianli Zou, Rui Chang & Xuehai Yan. (2020) Self‐Assembling Proteins for Design of Anticancer Nanodrugs. Chemistry – An Asian Journal 15:9, pages 1405-1419.
Crossref
Crossref
Mohammad A. Ansari, Ill-Min Chung, Govindasamy Rajakumar, Mohammad A. Alzohairy, Mohammad N. Alomary, Muthu Thiruvengadam, Faheem H. Pottoo & Niyaz Ahmad. (2020) Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review. Current Pharmaceutical Design 26:11, pages 1128-1137.
Crossref
Crossref
Tianzhong Li & Mengsu Yang. (2020) Vesicle Trafficking, Autophagy and Nanoparticles: A Brief Review. Current Nanomedicine 10:1, pages 3-19.
Crossref
Crossref
Gabriela N. Fazolin, Gustavo H.C. Varca, Slawomir Kadlubowski, Sebastian Sowinski & Ademar B. Lugão. (2020) The effects of radiation and experimental conditions over papain nanoparticle formation: Towards a new generation synthesis. Radiation Physics and Chemistry 169, pages 107984.
Crossref
Crossref
Imran Ali, Mosa Alsehli, Luciana Scotti, Marcus Tullius Scotti, Shang-Ting Tsai, Ruei-Siang Yu, Ming Fa Hsieh & Jung-Chih Chen. (2020) Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment. Polymers 12:3, pages 598.
Crossref
Crossref
Margaux Vigata, Christoph Meinert, Stephen Pahoff, Nathalie Bock & Dietmar W. Hutmacher. (2020) Gelatin Methacryloyl Hydrogels Control the Localized Delivery of Albumin-Bound Paclitaxel. Polymers 12:2, pages 501.
Crossref
Crossref
Sultan Erkan. (2020) Theoretical and Experimental Spectroscopic Properties and Molecular Docking of F8BT p-Type Semiconducting Polymer. Russian Journal of Physical Chemistry A 94:2, pages 445-452.
Crossref
Crossref
Dinobandhu Nandi, Anshula Sharma & Pranav Kumar Prabhakar. (2020) Nanoparticle-assisted Therapeutic Strategies for Effective Cancer Management. Current Nanoscience 16:1, pages 42-50.
Crossref
Crossref
Daniel Y. Zhang, Crismita Dmello, Li Chen, Victor A. Arrieta, Edgar Gonzalez-Buendia, J. Robert Kane, Lisa P. Magnusson, Aneta Baran, C. David James, Craig Horbinski, Alexandre Carpentier, Carole Desseaux, Michael Canney, Miguel Muzzio, Roger Stupp & Adam M. Sonabend. (2020) Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations. Clinical Cancer Research 26:2, pages 477-486.
Crossref
Crossref
Displaying 200 of 514 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list